Drug Trial Radar · NCT04546724
Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults
Last checked: Nov 19, 2026Latest source record: Jun 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
4,128
Actual
Start
Sep 17, 2020
Primary completion
May 19, 2021
Study completion Oct 15, 2021
Sponsor
- Lead sponsor
- Valneva Austria GmbHIndustry
- Sponsor type
- Industry
- First posted
- Sep 14, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This was a prospective, randomized, double-blinded, multicenter, pivotal clinical study evaluating the final dose of VLA1553 (1 x10E4 TCID50 per dose) in comparison to a placebo control. The final dose of VLA1553 or control was administered as single immunization on Day 1. Overall, 4.128 male and female subjects aged 18 years and above were randomized into the study.
Conditions
- Chikungunya Virus Infection
Interventions
VLA1553Biological
Single intramuscular vaccination on Day 1 with VLA1553, a lyophilized live-attenuated Chikungunya vaccine candidate; 1x10E4 TCID50 per dose
PlaceboBiological
Single intramuscular vaccination on Day 1 with Phosphate-Buffered Saline (PBS) as placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With a Seroprotective CHIKV Antibody Level for Baseline Negative Subjects 28 Days Post-vaccinationTime frame: on Day 29 after single vaccination
Locations
44 sites in 1 country. Site status is shown where the registry gives one.
Accelerated Enrollment Solutions (AES)
Chandler, Arizona
Accelerated Enrollment Solutions (AES)
Phoenix, Arizona
Alliance for Multispecialty Research (AMR)
Tempe, Arizona
ELITE Research Network (ELITE)
Little Rock, Arkansas
Velocity Clinical Research, Chula Vista
Chula Vista, California
Accelerated Enrollment Solutions (AES)
San Diego, California
Accel Research Sites - DeLand
DeLand, Florida
ELITE Research Network (ELITE)
Hallandale, Florida
Meridien Research - Maitland
Maitland, Florida
Accelerated Enrollment Solutions (AES)
Melbourne, Florida
Suncoast Research Group, LLC
Miami, Florida
ELITE Research Network (ELITE)
North Miami Beach, Florida
Jacksonville Center for Clinical Research, LTD dba St. Johns Center for Clinical Research
Ponte Vedra, Florida
Synexus - The Villages
The Villages, Florida
ELITE Research Network (ELITE)
Meridian, Idaho
Accelerated Enrollment Solutions (AES)
Chicago, Illinois
Accelerated Enrollment Solutions (AES)
Peoria, Illinois
Alliance for Multispecialty Research (AMR)
El Dorado, Kansas
Alliance for Multispecialty Research (AMR)
Newton, Kansas
Alliance for Multispecialty Research (AMR)
Wichita, Kansas
Alliance for Multispecialty Research (AMR)
Lexington, Kentucky
AMR - New Orleans - Center for Clinical Research
New Orleans, Louisiana
Alliance for Multispecialty Research (AMR)
Kansas City, Missouri
Meridian Clinical Research - Grand Island
Grand Island, Nebraska
Platinum Research Network (Platinum)
Omaha, Nebraska
Accelerated Enrollment Solutions (AES)
Omaha, Nebraska
Alliance for Multispecialty Research (AMR)
Las Vegas, Nevada
Meridian Clinical Research
Endwell, New York
Rochester Clinical Research
Rochester, New York
Lucas Research
Morehead City, North Carolina
ELITE Research Network (ELITE)
Wilmington, North Carolina
Accelerated Enrollment Solutions (AES)
Cincinnati, Ohio
ELITE Research Network (ELITE)
Oklahoma City, Oklahoma
Velocity Clinical Research - Medford
Medford, Oregon
Synexus - Anderson
Anderson, South Carolina
Vitalink Research - Anderson
Anderson, South Carolina
Alliance for Multispecialty Research (AMR)
Knoxville, Tennessee
Tekton Research - Beaumont
Beaumont, Texas
PanAmerican Clinical Research - US Headquarter
Brownsville, Texas
Velocity Clinical Research - Austin
Cedar Park, Texas
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.